Validity of Diagnosis Code–Based Claims to Identify Pulmonary NTM Disease in Bronchiectasis Patients
Jennifer H Ku, Emily Henkle, Kathleen F. Carlson, Miguel Marino, Kevin Winthrop
Abstract
Nontuberculous mycobacteria infection is increasing in incidence and can lead to chronic, debilitating pulmonary disease. We investigated the accuracy of diagnosis code-based nontuberculous mycobacteria lung disease claims among Medicare beneficiaries in the United States. We observed that these claims have moderate validity, but given their low sensitivity, incidence might be underestimated.
Topics & Concepts
BronchiectasisPulmonary diseaseMedicineDiseaseIntensive care medicinePathologyInternal medicineLungTracheal and airway disordersMycobacterium research and diagnosisCystic Fibrosis Research Advances